Competing Risks for Ventricular Tachyarrhythmias Prior to Death in Patients with Severely Impaired Renal Function with an Implantable Defibrillator

Ido Goldenberg Cardiology, Sheba Medical Center, Israel Tal Mor Cardiology, Sheba Medical Center, Israel Eyal Nof Cardiology, Sheba Medical Center, Israel Mahmoud Suleiman Cardiology, Rambam Medical Center, Israel Arwa Younis Cardiology, Sheba Medical Center, Israel Anat Berkovitch Cardiology, Sheba Medical Center, Israel Alon Barsheshet Cardiology, Rabin Medical Center, Israel Moshe Swissa Cardiology, Kaplan Medical Center, Israel Roy Beinart Cardiology, Sheba Medical Center, Israel

Background: Heart failure patients with advanced kidney disease (KD) may experience an increased rate of non-arrhythmic mortality due to associated comorbidities. We aimed to evaluate the competing risks between arrhythmic events and death in this high-risk population.

Methods: The study population comprised 3,542 patients who received an ICD for primary prevention and were enrolled and prospectively followed-up in the Israeli ICD registry. Study patients were categorized into two groups by the presence of advanced kidney disease: those with advanced KD, defined by a glomerular filtration rate (GFR) of

Results: Patients with advanced KD had higher rates of comorbidities. They were older with more advanced heart failure symptoms. Kaplan-Meier survival analysis showed that at 5-years of follow-up the rates of death without prior ICD shock were significantly higher in the advanced kidney disease group (46%) compared to the non-advanced KD group (19%) [log-rank P-value

Conclusion: ICD recipients for primary prevention with advanced KD (eGFR

Click the link to view image: https://events.eventact.com/dan/29113/104242.jpg
Ido Goldenberg
Ido Goldenberg
מרכז רפואי רמב"ם








Powered by Eventact EMS